EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia
- Theresa A. Zesiewicz
- , Susan Perlman
- , Kelly L. Sullivan
- , Jason Salemi
- , Yangxin Huang
- , Charles Isaacs
- , Matthew Klein
- , Jessica Shaw
- , Clifton Gooch
- , David Lynch
- University of South Florida
- Baylor College of Medicine
- University of Pennsylvania
- Edison Pharmaceuticals, Inc
Research output: Contribution to conference › Presentation